Last checked at 15 Nov 2017 11:47
Surgical Innovations Group plc
(the "Company")
Director/PDMR Shareholding
The Company was notified on 14 November 2017 that Adam Power, Group Development Director, had made the following purchases of ordinary shares of 1 penny each in the Company ("Shares") for his family.
Date | No. of Shares | Price |
27 September 2017 | 27,612 | 3.6p |
10 November 2017 | 29,690 | 3.348p |
Following the purchases, the beneficial holding of Adam Power is 31,307,302 Shares, representing approximately 4.0% of the issued share capital of the Company.
The information below, set out in accordance with the requirements of the EU Market Abuse
Regulation, provides further detail on shares acquired.
For further information please contact:
Surgical Innovations Group plc | www.sigroupplc.com |
Nigel Rogers, Executive Chairman | Tel: 0113 230 7597 |
Melanie Ross, COO & CFO |
|
|
|
WH Ireland Limited (NOMAD & Broker) | Tel: 0113 394 6600 |
Tim Feather Alex Bond |
|
|
|
Walbrook PR (Financial PR & Investor Relations) | Tel: 020 7933 8780 or si@walbrookpr.com |
Paul McManus | Mob: 07980 541 893 |
Lianne Cawthorne | Mob: 07584 391 303 |
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Adam Power | |||
2 | Reason for the notification | ||||
a) | Position/status | Group Development Director, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704 | |||
b) | Nature of the transactions | Purchases of Ordinary Shares | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
3.6p | 27,612 | ||||
| |||||
d) | Aggregated information - Aggregated volume - Price |
27,612 £994 | |||
e) | Date of the transaction | 27 September 2017 | |||
f) | Place of the transaction | London Stock Exchange, AIM | |||
1 | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name | Adam Power | |||
2 | Reason for the notification | ||||
a) | Position/status | Group Development Director, Surgical Innovations Group plc | |||
b) | Initial notification/ Amendment | Initial Notification | |||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Surgical Innovations Group plc | |||
b) | LEI | 2138004GHGUH3HUZE156 | |||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of 1p
GB0004016704 | |||
b) | Nature of the transactions | Purchases of Ordinary Shares | |||
c) | Price(s) and volume(s) |
| Price(s) | Volume(s) |
|
| 3.348p | 29,690 |
| ||
| |||||
d) | Aggregated information - Aggregated volume - Price |
29,690 £994 | |||
e) | Date of the transaction | 10 November 2017 | |||
f) | Place of the transaction | London Stock Exchange, AIM | |||